造船企业作业成本法应用及其局限探析

现代企业集团是伴随生产力发展到一定阶段形成的先进生产组织形式。本文从财务视角分析指出,其先进性体现在三个维度的财务协同模式上：一是通过适时控制外部经营环境风险,达到企业集团环境风险控制的财务协同;二是通过适时调整内部各类资源匹配的矛盾,形成企业集团资源重组匹配的财务协同;三是通过适时消解利益相关者的利益冲突,形成企业集团利益冲突协调的财务协同。研究表明,企业集团的协同发展依赖于外部环境的适应性、内部资源的匹配性、利益相关者的协调性。     

企业集团加强财务控制与监督研究

企业集团是由若干具有资本和产权联盟性质的企业形成的经济联合体,企业集团内部共享企业之间的利益、建立统一的经营战略和发展目标。为了适应高速发展的市场经济环境,大多数企业集团建立了财务控制体系,但是我国企业集团建立的财务控制体系尚不完善,存在问题。为此,企业集团需要建立有效的财务控制体系,完善财务控制和监督。     

浅论企业集团财务控制具体措施

企业集团发展的关键在于有效的财务控制,企业集团财务控制是指通过对企业集团中利益相关的组织、人员及财务资源的控制,合理配置资源,实现企业集团价值的最大化。本文分析了加强企业集团财务控制的具体措施。     

企业集团财务控制模式选择研究

当前,以资本为纽带。通过市场形成跨地区、跨行业、跨所有制、跨国经营的大型企业集团是国有企业战略重组的主要目标。在这一过程中。企业集团内部的财务控制关系着整个企业集团的生存与发展。如何加强企业集团内部财务控制。分散企业集团所面临的财务风险,是企业集团内部管理的重中之重。     

基于利益相关者的财务利益冲突与协调机制探讨

企业财务是一系列规定各利益相关者利益冲突、相互关系协调及其解决机制的契约联结，并且是企业财务治理的核心问题。其目的旨在合理分配企业剩余索取权和剩余控制权，并且明确各利益相关主体在财权分割与财权配置中的权利与责任，从而最终实现两者匹配得当。基于此，本文主要对利益相关者的财务利益冲突与协调机制进行探讨。     

博弈与企业集团财务控制

企业集团的财务控制过程是集团公司各利益相关者的博弈过程.集团公司总部为在各利益相关者的博弈中赢得利益平衡,应从集团公司整体利益出发,进行财务控制的博弈分析,设计解决集团公司财务控制存在问题的途径,从而有效实现集团公司利益最大化的财务目标.     

企业集团母子公司利益冲突与协调

企业集团母子公司利益关系协调的好坏直接关系着集团的管理效率和水平。加强企业集团母子公司利益关系的协调,对于降低企业集团财务风险、提升核心竞争力、实现企业集团健康有序发展具有十分重要的意义。本文阐述了企业集团母子公司之间的利益冲突,分析了冲突的原因,提出了母子公司利益关系协调的相关措施。     

三维财务风险预警理论模式及其指数预警矩阵新论——基于现金流量的财务风险三维分析模型及其预警指数体系研究

企业是一个开放性的法人实体型经营系统,需要通过财务组织不断地与“外部环境、内部流程和利益相关者”三个维度交换物质和信息并发生财务关系,以获取和配置资源,保障持续经营。三维财务风险（简称3DFR）是在企业持续经营的整个财务活动过程中产生的,具有积聚性、持久性、潜在性和可度量性等特点,其积聚与放大的结果是形成财务危机导致企业失败的根源,     

加强高校财务治理 提升财务管理效力

财务治理是基于所有权和控制权分离的现代企业制度提出的,要求理顺利益相关者责、权、利关系,实现剩余索取权和控制权间的合理匹配,形成良性激励约束机制,确保财务决策的科学性、财务行为的规范性及财务运行的高效性。财务管理是筹集并有效管理和使用组织资源,以实现组织既定目标。     

企业集团财务竞争力协同耦合机理研究

本文从财务战略协同、财务资源协同和财务关系协同三个方面入手,对企业集团财务竞争力的概念和内涵进行了阐释,分析了企业集团财务竞争力系统中各子系统的层次关系和协同耦合作用机理,建立了耦合测度模型。研究表明,企业集团财务竞争力的提升是财务战略协同、财务资源协同和财务关系协同耦合作用的结果。     

Financial constraints and synergy gains from mergers and acquisitions

This paper examines mergers and acquisitions motivated by financial constraints. Synergy gain is measured as the cumulative abnormal return of a value‐weighted portfolio of the acquirer and the target around the acquisition announcement. By constructing a financial constraint difference between the target and the acquirer, we find a positive relationship between the financial constraint difference and synergy gains generated from the acquisition. The positive effect of the financial constraint difference is only significant for high growth targets and severely constrained targets. The acquirer's corporate governance also enhances the synergy gains created from the financial constraint difference. Additional evidence shows that both acquirer's and target's shareholders benefit from the financial constraint difference. Our results are robust for different measures of financial constraint.     

金融新常态与经济新常态的协同发展分析——兼论金融供给侧结构性改革中解除金融抑制的进程

本文以金融抑制为研究主线,并作为经济新常态、金融新常态和金融供给侧结构性改革的结合点,解读金融供给侧结构性改革中解除金融抑制的进程并寻找金融新常态的现实依据,论述金融新常态与经济新常态的协同关系。结论如下:金融供给侧结构性改革效果良好,金融抑制的解除取得显著成效;我国金融发展步入新常态,且中国金融体系和金融发展具有内在稳定性;金融新常态与经济新常态相伴而生,金融新常态既是经济新常态的必然结果,也是经济新常态的客观表现。根据经济发展和金融供给侧结构性改革的历史经验,适应经济新常态、稳步推进金融供给侧结构性改革的建议为:在深化金融改革的同时,突出政府、市场和社会的协同作用;从内外两个角度实施金融供给侧结构性改革;中央和地方在解除金融抑制和深化金融改革时,应充分把控速度和质量,逐步推进金融供给侧结构性改革。     

中国上市企业并购的财务协同效应研究——聚焦于放大和紧缩

企业的并购是影响企业价值的重要经济活动,尤其是上市企业更是如此.研究以2006年发生的80起并购案例作为考察对象,首先通过计算差量来获取并购前一年、并购当年、并购后三年共计五年的财务时间序列数据;并采用差值分析方法分别对同业并购和混业并购所获得的财务协同效应进行比较,在通过有效性检验和主成分分析对财务协同效应的影响因素的基础上构建了主成分综合模型.研究得到的结论是:短期来看,我国上市企业并购的的财务协同存在着一种放大效应,但长期则显现出了财务协同的紧缩效应;长期看来同业并购资本使用效率上的放大效应更加能明显地持续下去;在偿债能力的放大效应上,短期内混业并购要优于同业并购,但在后期同业并购仍然要好于混业并购.所以我国企业在采取并购时,应该充分考虑自己的战略和并购目标,如果公司期望通过并购来提高自身的资本使用效率,采取混业并购战略更能达到这个目的;如果希望通过并购来进行业务的整合和扩张,那么企业应该采用同业并购的战略.     

High-involvement practices and performance of French firms

This article deals with the relationship between human resource practices (HRPs) and firm performances in France. It focuses on four specific HRPs that are able to involve employees: empowerment, compensation, communication and training. Each HRP taken in isolation is supposed to be positively related to performances because it is a source of motivation and commitment for employees. But there also exists a synergy between these practices: when they are combined into a bundle and are implemented all together, they should lead to better firm performances. A survey carried out among 180 human resource managers of large French companies leads to validation of most of our hypotheses. Contrary to previous research, we do not find a significant link between compensation and firm performance. The other HRPs are all indirectly related to financial performances, with social performance playing a mediating role. When they are combined into a bundle, HRPs have a stronger impact on performance than when they are studied individually. The article concludes with the importance of developing a strategic human resource policy and of implementing coherent and complementary high-involvement practices to increase firm performance.     

企业集团财权配置的契约结构分析

财权配置的契约安排是对企业集团初始（财务）契约的不完备性所进行的修正。财权配置的契约结构不仅决定企业集团与市场的边界,也决定企业集团内部代理成本的结构。而代理成本和财务协同效应均衡,可以实现企业集团财权配置契约结构的优化,即财权契约安排的制度净收益最大化。     

Theoretic insights on the nature of performance synergies in human resource systems: Toward greater precision

Synergy is a central tenet of the organizational level approach to human resource management (HRM). However, current theoretic treatments of synergy in the HRM literature are too inspecific to offer much insight about its essential characteristics in HRM systems. To move the treatment of synergy toward greater precision, this paper describes three different theoretic approaches to synergy in HRM systems: virtuous overlaps, independent effects, and efficient complementarities. Each of these approaches to synergy is better fitted to some contingencies than to others and is operationalized by different methodologies. Recognizing these different varieties of HRM system synergy allows researchers to better understand and estimate the impact of HRM systems on organizational performance. Moreover, the theoretic perspectives on synergy described here apply to many types of systems beyond HRM.     

Human resource management control system and firm performance: a contingency model of corporate control

This study explores how corporate controls used by the parent company of a conglomerate affect subsidiaries' human resource management (HRM) control–performance relationship. Empirical results from 93 firms reveal that the appropriate use of HRM control systems was a contributing factor to firm performance. When a subsidiary's approach to HRM was based on behavior control, performance was lower when the parent company emphasized financial control. When a subsidiary's approach to HRM was based on output control, performance was higher when the parent company emphasized either strategic or financial control. When a subsidiary's approach to HRM was based on input control, performance was higher when the parent company emphasized strategic control.     

中国现代金融体系的结构、影响及前景

在经济快速增长的背景下,中国已逐步形成一个以中央银行为核心、商业银行为主体,各种银行和非银行金融机构分工协作的现代国家金融体系。运用计量分析方法和典型相关分析,研究中国现代金融体系的社会融资结构、证券市场结构以及影子银行结构,测度国家现代金融体系对实体经济各行业的影响程度。研究表明:金融机构贷款与债券市场对相关行业的促进具有一定协同作用,股票市场对第一、二产业的发展影响较小,金融业对第三产业的促进作用最大。根据目前金融体系的结构、影响,可以预见未来中国现代金融体系的发展前景将主要体现在市场化、网络化以及国际化三个方面。     

对财政投资评审工作的思考与探索

财政作为国家宏观经济调控和资源配置及收入的重要手段,在社会主义市场经济运行中发挥着越来越重要的作用。本文通过对财政投资评审工作的特性进行论述供大家参考。     

Tapping Deep Pockets: The Role of Resources and Social Capital on Financial Capital Acquisition by Biotechnology Firms in Biotech–Pharma Alliances

Strategic alliances with pharmaceutical firms allow small biotechnology firms to acquire needed financial capital in exchange for sharing new, cutting‐edge technologies. This study draws from aspects of resource‐based view and social capital theory to examine the factors that influence the extent of financial capital biotech firms acquire when forming an alliance with pharmaceutical firms. Using a sample of 184 alliances from the period 1995–2000, we found that alliances where the pharmaceutical firm has greater management control are associated with greater acquisition of financial capital by the biotech firm. We also found that the credibility of the pharmaceutical firm is positively associated with the extent of financial capital acquired by the biotechnology firm and that the number of patents that the biotech firm has is negatively associated to the financial capital the biotech firm receives. We discuss the implications of our findings for theory, research, and management practice.